What was Lotus Pharmaceutical's revenue for May 2026?

Lotus Pharmaceutical recorded a revenue of NTD 2.32 billion (NTD 2,324,237 thousand), which is a 105.8% increase compared to May 2025.

What is the stock code and industry sector for Lotus Pharmaceutical?

The stock code is 1795 on the Taiwan Stock Exchange (TWSE), and it belongs to the Biotechnology and Medical Care sector.

What is driving Lotus Pharmaceutical's significant revenue growth?

The growth is primarily driven by strong export sales of high-barrier generic drugs, particularly oncology treatments, in global markets like the US.

AI News NQ Analysis

[Lotus Pharmaceutical] May 2026 Revenue Reached NTD 2.32 Billion (+105.8% YoY)

NQ Score 44/100

N1 Content Completeness 4

AI Summary (NQ-processed)

Lotus Pharmaceutical announced its consolidated revenue for May 2026 reached NTD 2.32 billion (NTD 2,324,237 thousand), a remarkable 105.8% increase compared to the same period last year, demonstrating highly robust global business growth.

AI Analysis

Frequently Asked Questions

Q: What was Lotus Pharmaceutical's revenue for May 2026?: A: Lotus Pharmaceutical recorded a revenue of NTD 2.32 billion (NTD 2,324,237 thousand), which is a 105.8% increase compared to May 2025.
Q: What is the stock code and industry sector for Lotus Pharmaceutical?: A: The stock code is 1795 on the Taiwan Stock Exchange (TWSE), and it belongs to the Biotechnology and Medical Care sector.
Q: What is driving Lotus Pharmaceutical's significant revenue growth?: A: The growth is primarily driven by strong export sales of high-barrier generic drugs, particularly oncology treatments, in global markets like the US.